{"id":2420,"date":"2019-09-02T23:00:00","date_gmt":"2019-09-02T21:00:00","guid":{"rendered":"https:\/\/poryatunok.info\/2019\/09\/02\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market\/"},"modified":"2019-09-02T23:00:00","modified_gmt":"2019-09-02T21:00:00","slug":"the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market","status":"publish","type":"post","link":"https:\/\/poryatunok.info\/en\/news-and-events\/news\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market\/","title":{"rendered":"The European Medicines Agency has approved the generic Volibris for the EU market"},"content":{"rendered":"<p>The European Medicines Agency has approved the generic Volibris for the EU market<br \/>Ambrisentan Mylan is a medication that is used alone or in combination with other medicines for the treatment of adults with pulmonary arterial hypertension (PAH).<br \/>Ambrisentan Mylan is used in patients with class II or III. Ambrisentan Mylan is effective for PAH without detectable cause and PAH caused by connective tissue disease.<br \/>Ambrisentan Mylan contains the active substance ambrisentan and is a &#8220;generic drug&#8221;. This means that Ambrisentan Mylan contains the same active substance and works in the same way as original medicines already authorized in the EU under the name Volibris.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The European Medicines Agency has approved the generic Volibris for the EU marketAmbrisentan Mylan is a medication that is used alone or in combination with other medicines for the treatment of adults with pulmonary arterial hypertension (PAH).Ambrisentan Mylan is used in patients with class II or III. Ambrisentan Mylan is effective for PAH without detectable [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4640,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-2420","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The European Medicines Agency has approved the generic Volibris for the EU market<\/title>\n<meta name=\"description\" content=\"The European Medicines Agency has approved the generic Volibris for the EU market\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/oktatasbazis.hu\/en\/news\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The European Medicines Agency has approved the generic Volibris for the EU market\" \/>\n<meta property=\"og:description\" content=\"The European Medicines Agency has approved the generic Volibris for the EU market\" \/>\n<meta property=\"og:url\" content=\"https:\/\/oktatasbazis.hu\/en\/news\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market\" \/>\n<meta property=\"og:site_name\" content=\"Sister Dalila\" \/>\n<meta property=\"article:published_time\" content=\"2019-09-02T21:00:00+00:00\" \/>\n<meta name=\"author\" content=\"SD Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"SD Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/oktatasbazis.hu\\\/en\\\/news\\\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/poryatunok.info\\\/en\\\/news-and-events\\\/news\\\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market\\\/\"},\"author\":{\"name\":\"SD Admin\",\"@id\":\"https:\\\/\\\/poryatunok.info\\\/en\\\/#\\\/schema\\\/person\\\/bde720c8f8473fd9c3ecae00f84cf471\"},\"headline\":\"The European Medicines Agency has approved the generic Volibris for the EU market\",\"datePublished\":\"2019-09-02T21:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/poryatunok.info\\\/en\\\/news-and-events\\\/news\\\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market\\\/\"},\"wordCount\":117,\"image\":{\"@id\":\"https:\\\/\\\/oktatasbazis.hu\\\/en\\\/news\\\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/poryatunok.info\\\/wp-content\\\/uploads\\\/sister-dalila-news-default-pic-1.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/poryatunok.info\\\/en\\\/news-and-events\\\/news\\\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market\\\/\",\"url\":\"https:\\\/\\\/oktatasbazis.hu\\\/en\\\/news\\\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market\",\"name\":\"The European Medicines Agency has approved the generic Volibris for the EU market\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/poryatunok.info\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/oktatasbazis.hu\\\/en\\\/news\\\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/oktatasbazis.hu\\\/en\\\/news\\\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/poryatunok.info\\\/wp-content\\\/uploads\\\/sister-dalila-news-default-pic-1.png\",\"datePublished\":\"2019-09-02T21:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/poryatunok.info\\\/en\\\/#\\\/schema\\\/person\\\/bde720c8f8473fd9c3ecae00f84cf471\"},\"description\":\"The European Medicines Agency has approved the generic Volibris for the EU market\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/oktatasbazis.hu\\\/en\\\/news\\\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/oktatasbazis.hu\\\/en\\\/news\\\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/oktatasbazis.hu\\\/en\\\/news\\\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market#primaryimage\",\"url\":\"https:\\\/\\\/poryatunok.info\\\/wp-content\\\/uploads\\\/sister-dalila-news-default-pic-1.png\",\"contentUrl\":\"https:\\\/\\\/poryatunok.info\\\/wp-content\\\/uploads\\\/sister-dalila-news-default-pic-1.png\",\"width\":1170,\"height\":796,\"caption\":\"Sister Dalila - \u041d\u043e\u0432\u0438\u043d\u0438, \u041d\u043e\u0432\u043e\u0441\u0442\u0438, News\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/oktatasbazis.hu\\\/en\\\/news\\\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/poryatunok.info\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The European Medicines Agency has approved the generic Volibris for the EU market\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/poryatunok.info\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/poryatunok.info\\\/en\\\/\",\"name\":\"Sister Dalila\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/poryatunok.info\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/poryatunok.info\\\/en\\\/#\\\/schema\\\/person\\\/bde720c8f8473fd9c3ecae00f84cf471\",\"name\":\"SD Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/25dbf52a07d74c8062368c48a6621c47703f6e82f7a8699bae496b69fc6c5499?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/25dbf52a07d74c8062368c48a6621c47703f6e82f7a8699bae496b69fc6c5499?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/25dbf52a07d74c8062368c48a6621c47703f6e82f7a8699bae496b69fc6c5499?s=96&d=mm&r=g\",\"caption\":\"SD Admin\"},\"url\":\"https:\\\/\\\/poryatunok.info\\\/en\\\/author\\\/sd-admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The European Medicines Agency has approved the generic Volibris for the EU market","description":"The European Medicines Agency has approved the generic Volibris for the EU market","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/oktatasbazis.hu\/en\/news\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market\/","og_locale":"en_US","og_type":"article","og_title":"The European Medicines Agency has approved the generic Volibris for the EU market","og_description":"The European Medicines Agency has approved the generic Volibris for the EU market","og_url":"https:\/\/oktatasbazis.hu\/en\/news\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market","og_site_name":"Sister Dalila","article_published_time":"2019-09-02T21:00:00+00:00","author":"SD Admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"SD Admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/oktatasbazis.hu\/en\/news\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market#article","isPartOf":{"@id":"https:\/\/poryatunok.info\/en\/news-and-events\/news\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market\/"},"author":{"name":"SD Admin","@id":"https:\/\/poryatunok.info\/en\/#\/schema\/person\/bde720c8f8473fd9c3ecae00f84cf471"},"headline":"The European Medicines Agency has approved the generic Volibris for the EU market","datePublished":"2019-09-02T21:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/poryatunok.info\/en\/news-and-events\/news\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market\/"},"wordCount":117,"image":{"@id":"https:\/\/oktatasbazis.hu\/en\/news\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market#primaryimage"},"thumbnailUrl":"https:\/\/poryatunok.info\/wp-content\/uploads\/sister-dalila-news-default-pic-1.png","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/poryatunok.info\/en\/news-and-events\/news\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market\/","url":"https:\/\/oktatasbazis.hu\/en\/news\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market","name":"The European Medicines Agency has approved the generic Volibris for the EU market","isPartOf":{"@id":"https:\/\/poryatunok.info\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/oktatasbazis.hu\/en\/news\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market#primaryimage"},"image":{"@id":"https:\/\/oktatasbazis.hu\/en\/news\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market#primaryimage"},"thumbnailUrl":"https:\/\/poryatunok.info\/wp-content\/uploads\/sister-dalila-news-default-pic-1.png","datePublished":"2019-09-02T21:00:00+00:00","author":{"@id":"https:\/\/poryatunok.info\/en\/#\/schema\/person\/bde720c8f8473fd9c3ecae00f84cf471"},"description":"The European Medicines Agency has approved the generic Volibris for the EU market","breadcrumb":{"@id":"https:\/\/oktatasbazis.hu\/en\/news\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/oktatasbazis.hu\/en\/news\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/oktatasbazis.hu\/en\/news\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market#primaryimage","url":"https:\/\/poryatunok.info\/wp-content\/uploads\/sister-dalila-news-default-pic-1.png","contentUrl":"https:\/\/poryatunok.info\/wp-content\/uploads\/sister-dalila-news-default-pic-1.png","width":1170,"height":796,"caption":"Sister Dalila - \u041d\u043e\u0432\u0438\u043d\u0438, \u041d\u043e\u0432\u043e\u0441\u0442\u0438, News"},{"@type":"BreadcrumbList","@id":"https:\/\/oktatasbazis.hu\/en\/news\/the-european-medicines-agency-has-approved-the-generic-volibris-for-the-eu-market#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/poryatunok.info\/en\/"},{"@type":"ListItem","position":2,"name":"The European Medicines Agency has approved the generic Volibris for the EU market"}]},{"@type":"WebSite","@id":"https:\/\/poryatunok.info\/en\/#website","url":"https:\/\/poryatunok.info\/en\/","name":"Sister Dalila","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/poryatunok.info\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/poryatunok.info\/en\/#\/schema\/person\/bde720c8f8473fd9c3ecae00f84cf471","name":"SD Admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/25dbf52a07d74c8062368c48a6621c47703f6e82f7a8699bae496b69fc6c5499?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/25dbf52a07d74c8062368c48a6621c47703f6e82f7a8699bae496b69fc6c5499?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/25dbf52a07d74c8062368c48a6621c47703f6e82f7a8699bae496b69fc6c5499?s=96&d=mm&r=g","caption":"SD Admin"},"url":"https:\/\/poryatunok.info\/en\/author\/sd-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/poryatunok.info\/en\/wp-json\/wp\/v2\/posts\/2420","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/poryatunok.info\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/poryatunok.info\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/poryatunok.info\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/poryatunok.info\/en\/wp-json\/wp\/v2\/comments?post=2420"}],"version-history":[{"count":0,"href":"https:\/\/poryatunok.info\/en\/wp-json\/wp\/v2\/posts\/2420\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/poryatunok.info\/en\/wp-json\/wp\/v2\/media\/4640"}],"wp:attachment":[{"href":"https:\/\/poryatunok.info\/en\/wp-json\/wp\/v2\/media?parent=2420"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/poryatunok.info\/en\/wp-json\/wp\/v2\/categories?post=2420"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/poryatunok.info\/en\/wp-json\/wp\/v2\/tags?post=2420"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}